Cargando…
Pharmacological Efficacy and Gastrointestinal Safety of Different Aspirin Formulations for Cardiovascular Prevention: A Narrative Review
Aspirin inhibits platelet function by irreversibly inhibiting the synthesis of thromboxane A2 (TxA2). Aspirin, at low doses, is widely used for cardiovascular prevention. Gastrointestinal discomfort, mucosal erosions/ulcerations and bleeding are frequent complications of chronic treatment. To reduce...
Autores principales: | Clerici, Bianca, Cattaneo, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145431/ https://www.ncbi.nlm.nih.gov/pubmed/37103016 http://dx.doi.org/10.3390/jcdd10040137 |
Ejemplares similares
-
Aspirin in essential thrombocythemia. For whom? What formulation? What regimen?
por: Cattaneo, Marco
Publicado: (2023) -
The Efficacy And Safety Of Aspirin As The Primary Prevention Of Cardiovascular Disease: An Updated Meta-Analysis
por: Xie, Wenchao, et al.
Publicado: (2019) -
Aspirin for Prevention of Cardiovascular Disease
por: Mendy, Vincent L., et al.
Publicado: (2017) -
Efficacy and Safety of Novel Aspirin Formulations: A Randomized, Double-Blind, Placebo-Controlled Study
por: Mollace, Rocco, et al.
Publicado: (2022) -
Aspirin and Infection: A Narrative Review
por: Di Bella, Stefano, et al.
Publicado: (2022)